Feedback / Questions
bersiporocin (DWN12088) - Daewoong Pharma, Biocon
https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-third-idmc-reaffirms-safety-of-bersiporocin-and-recommends-continuation-of-global-phase-2-clinical-trial-302595005.html
Oct 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next